First human test for potential diabetes treatment begins
Disease control
Completed
This small, early-stage study tested the safety and side effects of a new oral treatment called R-5280 in teenagers recently diagnosed with Type 1 diabetes. For 12 weeks, participants took either the treatment or a placebo pill. Researchers checked for side effects and also measu…
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC